BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4876972)

  • 1. The metabolism of N-triphenylmethylmorpholine in the dog and rat.
    Griffiths MH
    Biochem J; 1968 Aug; 108(5):731-40. PubMed ID: 4876972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution and excretion in urine, feces and respiratory CO2 of [14C]-ciclosidomine in beagle dogs.
    Matteo MR; Zavorskas P; Esber H
    Arzneimittelforschung; 1985; 35(1A):329-32. PubMed ID: 3921036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolism of arylazoisoxazolones by rats and dogs.
    Daniel JW
    Biochem J; 1969 Mar; 111(5):695-702. PubMed ID: 5783470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats.
    Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S
    Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolites of 2-(3-trifluoromethylphenyl)tetrahydro-1,4-oxazine (CERM) 1841) in rats and dogs.
    Kucharczyk N; Yang JT; Valia KH; Stiefel FJ; Sofia RD
    Xenobiotica; 1979 Nov; 9(11):703-11. PubMed ID: 532219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of 2-chloro-1-(2',4'-dichlorophenyl)vinyl diethyl phosphate (Chlorfenvinphos) in the dog and rat.
    Hutson DH; Akintonwa DA; Hathway DE
    Biochem J; 1967 Jan; 102(1):133-42. PubMed ID: 6030274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of saccharin in animals.
    Lethco EJ; Wallace WC
    Toxicology; 1975; 3(3):287-300. PubMed ID: 1092032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.
    Denissen JF; Grabowski BA; Johnson MK; Boyd SA; Uchic JT; Stein H; Cepa S; Hill P
    Drug Metab Dispos; 1994; 22(6):880-8. PubMed ID: 7895605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.
    Hawkins DR; Weston KT; Chasseaud LF; Darragh A; O'Kelly A
    Eur J Drug Metab Pharmacokinet; 1980; 5(3):135-43. PubMed ID: 7202431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative metabolism of 2,6-dichlorothiobenzamide (Prefix) and 2,6-dichlorobenzonitrile in the dog and rat.
    Griffiths MH; Moss JA; Rose JA; Hathway DE
    Biochem J; 1966 Mar; 98(3):770-81. PubMed ID: 5911525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE FATE OF 2,4,6-TRI-(3',5'-DI-TERT.-BUTYL-4'-HYDROXYBENZYL)MESITYLENE (IONOX 330) IN THE DOG AND RAT.
    WRIGHT AS; CROWNE RS; HATHWAY DE
    Biochem J; 1965 Apr; 95(1):98-103. PubMed ID: 14333573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of metabolites of benz(j)aceanthrylene in faeces, urine and bile from rat.
    Hegstad S; Lundanes E; Holme JA; Alexander J
    Xenobiotica; 1999 Dec; 29(12):1257-72. PubMed ID: 10647911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of the local anaesthetic fomocaine (1-morpholino-3-[p-phenoxymethylphenyl]propane) in the rat and dog after oral application.
    Oelschläger HA; Temple DJ; Temple CF
    Xenobiotica; 1975 May; 5(5):309-23. PubMed ID: 1154806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of di-(3,5-di-tert.-butyl-4-hydroxyphenyl)methane (Ionox 22) in the rat.
    Wright AS; Crowne RS; Hathway DE
    Biochem J; 1966 Apr; 99(1):146-54. PubMed ID: 5965331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influences of the route of administration on the metabolism and excretion of bitolterol, a new bronchodilator, in the rat.
    Aimoto T; Ito O; Kimura R; Murata T; Ito K
    Xenobiotica; 1979 Mar; 9(3):173-80. PubMed ID: 473792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
    Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
    Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.